Navigation Links
NeurogesX to Provide Qutenza® Launch Update
Date:2/9/2011

SAN MATEO, Calif., Feb. 9, 2011 /PRNewswire/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will hold a conference call on February 14, 2011 at 4:30 p.m. ET (1:30 p.m. PT) to provide an update on the U.S. commercial launch of Qutenza® (capsaicin) 8% patch for the management of neuropathic pain associated with postherpetic neuralgia (PHN).

NeurogesX will highlight key metrics for tracking U.S. physician adoption during the three month period ended December 31, 2010, approximately one month prior to filing fourth quarter 2010 financial results.

The conference call will be hosted by Anthony DiTonno, President and Chief Executive Officer, and Stephen Ghiglieri, Executive Vice President, Chief Operating Officer and Chief Financial Officer.

To participate, please dial 1-877-407-0789 (USA) or 1-201-689-8562 (International).  To access the live web cast please visit the Investor Relations section on the corporate web site at http://www.neurogesx.com.

A replay of the conference call will be available beginning February 14, 2011 at 8:00 p.m. ET (5:00 p.m. PT) and ending on February 24, 2011 by dialing 1-877-870-5176 (USA) or 1-858-384-5517 (International) with Conference ID Number: 367175.  A replay of the webcast will also be available on the corporate website through March 14, 2011.

The call will be webcast live and archived for 90 days on the investor relations section of NeurogesX' website at www.neurogesx.com.

About NeurogesX, Inc.

NeurogesX, Inc. (Nasdaq: NGSX) is a San Francisco Bay Area-based biopharmaceutical company focused on developing and co
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NeurogesX to Present at Two February Investor Conferences
2. NeurogesX Receives Qutenza®-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
3. NeurogesX Doses First Patient in Phase 2 Clinical Study of NGX-1998 Liquid Capsaicin Formulation
4. NeurogesX to Hold Conference Call to Discuss Third Quarter 2010 Results
5. NeurogesX to Present at Oppenheimer & Co Healthcare Conference
6. Although NeurogesX/Astellass Qutenza is Only Approved for Postherpetic Neuralgia, Surveyed U.S. Physicians are Likely to Prescribe It for All Neuropathic Pain Types
7. NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
8. NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)
9. NeurogesX Expands Commercial Operations Leadership Team
10. NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
11. NeurogesX to Present at JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... CLEVELAND , May 22, 2013 /PRNewswire/ ... Software,s enterprise content management (ECM) ... Meditech,s Hospital Information System .  These organizations ... IT system and will use OnBase to ... corporate initiatives.   (Logo:  ...
(Date:5/22/2013)... STEPh, Inc., a full service medical communications ... web site ( http://www.stephreports.com ) dedicated to ... STEPh Reports STEPh Reports are comprehensive critical ... STEPh Report assesses the competitive landscape by individual drug ... and specific key issues.  STEPh Reports are written by ...
(Date:5/22/2013)... , May 22, 2013   Life Line ... screening services announced today the creation of a unique ... . MCM is a population health ... MCM,s growing list of clients. These important expanded services ... chronic conditions earlier. Effective prevention reduces cost of care ...
Breaking Medicine Technology:Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 2Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 3Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2
... for prostate cancer treatment medications from Dendreon and ... with advanced prostate cancer were prolonged almost four ... The drug, which could reach the market in 2011, is ... to change clinical practice by providing a new treatment option ...
... ( www.pneumrx.com ), a medical device company dedicated to ... disease, today announced that it has received CE Mark ... System to treat the later stages of emphysema.   ... invasive device intended to improve lung function in emphysema ...
Cached Medicine Technology:Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone 2PneumRx, Inc. Announces CE Mark Approval for Its RePneu® Lung Volume Reduction Coil (LVRC™) System 2
(Date:5/22/2013)... People in the United States have been ... shortages. In much of the world, water shortages are normal ... Kleyne. She warns against taking water for granted and provides ... so easily in the United States. , Sharon Kleyne is ... show, heard live or by podcast on World Talk Radio, ...
(Date:5/22/2013)... New York (PRWEB) May 22, 2013 ... version of the DePuy Pinnacle Hip Replacement System continue ... Texas Federal Court, Bernstein Liebhard LLP reports. According ... directed DePuy Orthopaedics to produce monitoring reports associated with ... the company’s medical device marketing practices. Plaintiffs maintained ...
(Date:5/22/2013)... Diversity Focus and Handicap This Productions announce ... promotes awareness that physical disabilities do not stop people ... be held Friday, June 14th at 7:30 p.m. at ... Handicap This! can be purchased at http://www.diversityfocus.org . ... to which their mind is handicap accessible. Mike ...
(Date:5/22/2013)... Twenty student-led startup companies at Arizona State University ... startup accelerator designed to help them execute their business ... jobs as part of ASU’s Edson Student Entrepreneur ... approximately 20 student teams up to $20,000 each in ... their for-profit, more-than-profit or nonprofit ventures. The program, which ...
(Date:5/22/2013)... ANN ARBORA University of Michigan study challenges previous ... League Baseball. , The study, a collaboration between ... and Florida, looks deeper into the controversial argument ... more strikes for pitchers of the same race. ... claim, said Jason Winfree, associate professor of sport ...
Breaking Medicine News(10 mins):Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 3Health News:Handicap This! Comes to Marion, Iowa 2Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 2Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 3Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 4Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 5Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 6Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 7Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 8Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 9Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2
... ... an occupational health nurse. , ... Franklin, Tenn. (Vocus) February 25, 2010 -- Kathy Dayvault, RN, MPH, ... than two decades of experience in occupational health and safety, Dayvault will provide support ...
... ... ... , ... , , , ...
... ... ... , , ... ...
... 1 March 2010 - Conventional antidepressant treatments generally require ... discovery of treatments with a more rapid onset is ... drug found to produce rapid improvement in mood was ... In a new issue of Biological Psychiatry , ...
... Ohio If the behavior of the seasonal form of ... chances are good that most strains of the pandemic H1N1 ... stockpiled for use against it. Researchers at Ohio State ... influenza virus, which first infected humans during the 1918 pandemic. ...
... ... , ... 2010 -- Screenings of inner-city Pittsburgh children show an alarming number of young asthmatics with ... are not being diagnosed or treated, according to a study led by researchers at Allegheny ...
Cached Medicine News:Health News:Occupational Health Expert Expands PureSafety's Growing Strategic Resources Team 2Health News:Acuo Technologies Announces Enhanced Offerings That Facilitate Management of Non-DICOM Objects 2Health News:Acuo Technologies Announces Enhanced Offerings That Facilitate Management of Non-DICOM Objects 3Health News:Maria D. Solomon is Recognized by Continental Who’s Who Among Health Care Professionals 2Health News:A new generation of rapid-acting antidepressants? 2Health News:Pandemic flu, like seasonal H1N1, shows signs of resisting Tamiflu 2Health News:Pandemic flu, like seasonal H1N1, shows signs of resisting Tamiflu 3Health News:Pandemic flu, like seasonal H1N1, shows signs of resisting Tamiflu 4Health News:AGH Study Shows High Rates of Poorly Controlled Asthma Among Inner-City Pittsburgh Children 2
Micro-retractor arm 12"....
... designed for the retraction of nerves, vessels, tissue, ... Equalizes brain retraction pressure. Decreases shear injury to ... conjunction with the Budde Halo Retractor. Range of ... 2 mm and 4 mm wide. Quick change ...
Telescopic Diamond-Dissectors for delicate sharp tissue preparation. Total/working lengths 220/240 mm with protective sleeve....
Cone Ring Curettes, length 9" (229 mm), ring diameter (I.D.) 5/16" (8 mm)....
Medicine Products: